Related Experiment Video
Updated: Feb 21, 2026
06:39
Real-Time Void Spot Assay
Published on: February 10, 2023
2.7K
[Correction of age related bladder function decrease with peptide geroprotector in women].
V G Gomberg1, A P Ryzhak1, R V Lyutov1
1Saint-Petersburg Institute of Bioregulation and Gerontology, St. Peterburg, 197110, Russian Federation; galina@gerontology.ru.
Advances in Gerontology = Uspekhi Gerontologii
|October 5, 2017
Summary
Peptide bioregulator Chitomur® effectively treats hyperactive bladder in older women, improving bladder function and quality of life without side effects. This offers a promising alternative to current treatments.
Area of Science:
- Gerontology
- Urology
- Pharmacology
Context:
- Hyperactive bladder (OAB) significantly impacts the quality of life for aging women.
- Current OAB treatments often have limitations and side effects.
- Peptide bioregulators represent a novel therapeutic approach.
Purpose:
- To evaluate the efficacy of the peptide bioregulator Chitomur® in postmenopausal women with OAB.
- To assess the impact of Chitomur® on urodynamic parameters and patient-reported quality of life.
- To compare the safety profile of Chitomur® with existing OAB medications.
Summary:
- A randomized, blind study involving women aged 48-80 with OAB was conducted.
- Chitomur® administration led to reduced urinary urgency and incontinence episodes.
- Significant improvements in bladder condition and patient-reported anxiety were observed.
Impact:
- Chitomur® demonstrated a favorable safety profile with no detected side effects.
- The study suggests Chitomur® enhances quality of life by alleviating anxiety associated with OAB symptoms.
- Chitomur® presents a potentially safer and effective therapeutic option for managing OAB in aging women.
Related Concept Videos
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
748
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
748
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
274
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
274
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
287
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
287
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
257
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
257
01:15Drug Dosing: Geriatric Patients
308
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
308
01:28Menopause
5.0K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.0K